Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 15459213)

Published in J Clin Oncol on October 01, 2004

Authors

L Bomgaars1, J R Geyer, J Franklin, G Dahl, J Park, N J Winick, R Klenke, S L Berg, S M Blaney

Author Affiliations

1: Texas Children's Cancer Center/Baylor College of Medicine, 6621 Fannin, MC 3-3320, Houston, TX 77030, USA. lbomgaars@txccc.org

Articles citing this

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine (2006) 4.08

Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol (2009) 1.21

Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood (2012) 1.07

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy. Mediterr J Hematol Infect Dis (2014) 0.90

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma. Haematologica (2010) 0.82

Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). Pediatr Blood Cancer (2011) 0.82

Intrathecal liposomal cytarabine: more friend than foe? Leuk Lymphoma (2008) 0.81

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Med Oncol (2015) 0.77

Advances in paediatric cancer treatment. Transl Pediatr (2014) 0.76

Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma. Bone Marrow Transplant (2016) 0.75

Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia. Leuk Res (2011) 0.75

Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome. Clin Investig (Lond) (2011) 0.75

Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation. Front Pediatr (2017) 0.75

Intracranial hypertension following intrathecal administration of liposomal cytarabine. J Neurol (2010) 0.75

Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution. Invest New Drugs (2011) 0.75

Intrathecal chemotherapy for refractory disseminated medulloblastoma. Childs Nerv Syst (2007) 0.75

Articles by these authors

(truncated to the top 100)

DaliLite workbench for protein structure comparison. Bioinformatics (2000) 10.53

Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A (2001) 7.51

Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80

Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13

ZnO nanowire UV photodetectors with high internal gain. Nano Lett (2007) 6.06

Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol (2001) 5.78

Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics (2001) 4.30

Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc (2001) 4.28

Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev (2000) 4.10

Biotechnology awareness study, Part 1: Where scientists get their information. Bull Med Libr Assoc (1991) 3.85

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68

The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A (2008) 3.41

Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet (1976) 3.41

Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA (1999) 3.14

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia (2008) 3.10

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08

Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem (1997) 2.95

Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol Cell Biol (1993) 2.73

P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol (2008) 2.49

Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg (1996) 2.33

A fully automatic evolutionary classification of protein folds: Dali Domain Dictionary version 3. Nucleic Acids Res (2001) 2.32

A new approach to monitoring exercise training. J Strength Cond Res (2001) 2.30

Expression of functional cell-cell channels from cloned rat liver gap junction complementary DNA. Science (1987) 2.30

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24

PartsList: a web-based system for dynamically ranking protein folds based on disparate attributes, including whole-genome expression and interaction information. Nucleic Acids Res (2001) 2.23

Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg (1998) 2.22

Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA. Mol Cell Biol (1984) 2.21

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol (1997) 2.14

Formation of hybrid cell-cell channels. Proc Natl Acad Sci U S A (1989) 2.14

Changing pattern of drugs used for self-poisoning. Br Med J (1978) 2.11

Structural assignments to the Mycoplasma genitalium proteins show extensive gene duplications and domain rearrangements. Proc Natl Acad Sci U S A (1998) 2.08

Fast assignment of protein structures to sequences using the intermediate sequence library PDB-ISL. Bioinformatics (2000) 2.04

New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell (1984) 1.99

Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem (2001) 1.99

Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol (1991) 1.97

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol (1999) 1.95

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol (1995) 1.94

Acute poisoning with maprotiline hydrochloride. Br Med J (1977) 1.89

Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol (1997) 1.88

The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int (2007) 1.82

Activation of the DNA-binding ability of human heat shock transcription factor 1 may involve the transition from an intramolecular to an intermolecular triple-stranded coiled-coil structure. Mol Cell Biol (1994) 1.76

Survival after implantation of the cardioverter defibrillator. Am J Cardiol (1992) 1.76

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem (1996) 1.73

Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res (1992) 1.72

Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis. Scand J Rheumatol (1996) 1.70

Identification of a pore lining segment in gap junction hemichannels. Biophys J (1997) 1.69

Gating of cx46 gap junction hemichannels by calcium and voltage. Pflugers Arch (1999) 1.69

Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 1.68

Giant piezoelectricity on Si for hyperactive MEMS. Science (2011) 1.66

A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature (1996) 1.66

An epidemiologic study of risk factors in two teenage suicide clusters. JAMA (1989) 1.65

Laparoscopic removal of a large colonic lipoma. Report of a case. Dis Colon Rectum (1991) 1.64

Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J (1974) 1.63

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia (2005) 1.63

Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood (1995) 1.62

Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A (1995) 1.61

Functional relationships and structural determinants of two bacteriophage T4 lysozymes: a soluble (gene e) and a baseplate-associated (gene 5) protein. New Biol (1989) 1.59

Decoupling of heart muscle cells: correlation with increased cytoplasmic calcium activity and with changes of nexus ultrastructure. J Membr Biol (1980) 1.58

Depression-related cognitions: antecedent or consequence? J Abnorm Psychol (1981) 1.58

Biphenyl and benzoate metabolism in a genomic context: outlining genome-wide metabolic networks in Burkholderia xenovorans LB400. Appl Environ Microbiol (2004) 1.56

Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene (2006) 1.56

Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. AJNR Am J Neuroradiol (2010) 1.53

Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav (2006) 1.49

Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci U S A (1998) 1.48

Ventilation and acid-base changes in deep coma due to barbiturate or tricyclic antidepressant poisoning. Clin Toxicol (1977) 1.47

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.47

Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology (1998) 1.46

Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood (1998) 1.45

Complete sequence of enzootic nasal tumor virus, a retrovirus associated with transmissible intranasal tumors of sheep. J Virol (1999) 1.44

Localization of a voltage gate in connexin46 gap junction hemichannels. Biophys J (1998) 1.39

Effect of low neutral endopeptidase expression on response to fMLP. J Lab Clin Med (1992) 1.39

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis (1992) 1.39

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol (2001) 1.38

A chimeric connexin forming gap junction hemichannels. Pflugers Arch (1997) 1.38

Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase. J Virol (1999) 1.37

Cell junction and cyclic AMP: 1. Upregulation of junctional membrane permeability and junctional membrane particles by administration of cyclic nucleotide or phosphodiesterase inhibitor. J Membr Biol (1981) 1.37

Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily. Yeast (1997) 1.36

Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Neuroscience (2007) 1.33

Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology (1999) 1.31

Growth substrate- and phase-specific expression of biphenyl, benzoate, and C1 metabolic pathways in Burkholderia xenovorans LB400. J Bacteriol (2005) 1.30

Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res (2000) 1.28

Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2002) 1.28

Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol (2000) 1.28

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol (1996) 1.27

Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature. Clin Infect Dis (1992) 1.25

The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. Blood (1991) 1.23

Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38 MAPK-dependent pathway. J Biol Chem (2000) 1.22

Structure of a gap junction gene: rat connexin-32. Biosci Rep (1988) 1.22

Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol (1999) 1.22

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol (2001) 1.22

Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol (2001) 1.21

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol (2001) 1.21

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med (1999) 1.21

Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). FEBS Lett (2000) 1.21

Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol (1995) 1.20

Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus (2010) 1.20